Dll4 Blockade Promotes Angiogenesis in Nonhealing Wounds of Sox7-Deficient Mice

Cited 0 time in webofscience Cited 0 time in scopus
  • Hit : 64
  • Download : 8
Objective: This study aimed to elucidate the role of the proangiogenic transcription factors Sox7 and Sox17 in the wound healing process and investigate the therapeutic potential of Dll4 blockade, which is an upstream regulator of Sox17, for the treatment of nonhealing wounds. Approach: After generating a full-thickness skin defect wound model of endothelial Sox7- and/or Sox17-deficient mice, we measured the wound healing rates and performed histological analysis. The effects of an anti-Dll4 antibody on wound angiogenesis in Sox7-deficient mice and db/db diabetic mice were assessed. Results: Sox7 and/or Sox17 deletion delayed wound healing. Moreover, the loss of Sox7 and Sox17 inhibited wound angiogenesis, without affecting the expression of the other. Of interest, after anti-Dll4 antibody treatment, Sox17 levels were increased and the suppression of angiogenesis was alleviated in Sox7-deficient mice and db/db diabetic mice. Consequently, Dll4 blockade effectively recovered the observed delay in wound healing. Innovation: The proangiogenic role of Sox7 and Sox17 in wound angiogenesis was addressed and effective treatment of nonhealing wounds by Dll4 blockade was suggested. Conclusion: This study revealed the proangiogenic role of the transcription factors Sox7 and Sox17 in wound angiogenesis. Furthermore, we suggest a novel method for treating nonhealing wounds by particularly targeting the Dll4-Sox17 axis.
Publisher
MARY ANN LIEBERT, INC
Issue Date
2020-11
Language
English
Article Type
Article
Citation

ADVANCES IN WOUND CARE, v.9, no.11, pp.591 - 601

ISSN
2162-1918
DOI
10.1089/wound.2019.1015
URI
http://hdl.handle.net/10203/278211
Appears in Collection
MSE-Journal Papers(저널논문)
Files in This Item
000581603500001.pdf(1.94 MB)Download

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0